These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22294602)

  • 41. "Large pore size" virus filter test method recommended by the PDA Virus Filter Task Force.
    Brorson K; Sofer G; Robertson G; Lute S; Martin J; Aranha H; Haque M; Satoh S; Yoshinari K; Moroe I; Morgan M; Yamaguchi F; Carter J; Krishnan M; Stefanyk J; Etzel M; Riorden W; Korneyeva M; Sundaram S; Wilkommen H; Wojciechowski P
    PDA J Pharm Sci Technol; 2005; 59(3):177-86. PubMed ID: 16048117
    [No Abstract]   [Full Text] [Related]  

  • 42. Mechanisms in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 23-25, 1988. Proceedings.
    Curr Top Microbiol Immunol; 1988; 141():1-340. PubMed ID: 3265084
    [No Abstract]   [Full Text] [Related]  

  • 43. Gamma-irradiation of serum for the inactivation of adventitious contaminants.
    Gauvin G; Nims R
    PDA J Pharm Sci Technol; 2010; 64(5):432-5. PubMed ID: 21502047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A consensus rating method for small virus-retentive filters. I. Method development.
    Lute S; Riordan W; Pease LF; Tsai DH; Levy R; Haque M; Martin J; Moroe I; Sato T; Morgan M; Krishnan M; Campbell J; Genest P; Dolan S; Tarrach K; Meyer A; ; Zachariah MR; Tarlov MJ; EtzeL M; Brorson K; Aranha H; Bailey M; Bender J; Carter J; Chen Q; Dowd C; Jani R; Jen D; Kidd S; Meltzer T; Remington K; Rice I; Romero C; Sato T; Jornitz M; Sekura CM; Sofer G; Specht R; Wojciechowski P;
    PDA J Pharm Sci Technol; 2008; 62(5):318-33. PubMed ID: 19055228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
    Aronow WS; Fleg JL; Pepine CJ; Artinian NT; Bakris G; Brown AS; Ferdinand KC; Forciea MA; Frishman WH; Jaigobin C; Kostis JB; Mancia G; Oparil S; Ortiz E; Reisin E; Rich MW; Schocken DD; Weber MA; Wesley DJ; Harrington RA;
    Circulation; 2011 May; 123(21):2434-506. PubMed ID: 21518977
    [No Abstract]   [Full Text] [Related]  

  • 46. Statistical Methods for the Analysis of Discrete-Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.
    Prosser LA
    Value Health; 2016 Jun; 19(4):298-9. PubMed ID: 27325320
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular Diagnostics--Select Biosciences' Second World Congress. 6-7 August 2009, South San Francisco, CA, USA.
    Bodowitz S
    IDrugs; 2009 Oct; 12(10):627-8. PubMed ID: 19790011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products. Proceedings of a meeting. Bethesda, Maryland, USA, June 14-16, 1995.
    Dev Biol Stand; 1996; 88():1-342. PubMed ID: 9119120
    [No Abstract]   [Full Text] [Related]  

  • 49. Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems.
    Knapp JZ
    PDA J Pharm Sci Technol; 2003; 57(2):131-9. PubMed ID: 14674515
    [No Abstract]   [Full Text] [Related]  

  • 50. Oncogenes in B-cell neoplasia. Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 5-7,1984.
    Curr Top Microbiol Immunol; 1984; 113():1-268. PubMed ID: 6332708
    [No Abstract]   [Full Text] [Related]  

  • 51. Conference report: the 5th cell-based assay and bioanalytical method development conference.
    Ma M
    Bioanalysis; 2011 Jan; 3(2):137-40. PubMed ID: 21250842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Report of the ASHP Task Force on Racial Diversity, Equity, and Inclusion.
    Am J Health Syst Pharm; 2021 May; 78(10):903-906. PubMed ID: 33954425
    [No Abstract]   [Full Text] [Related]  

  • 53. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs.
    Madjid M; Luepker RV; Greenland KJ; Taubert KA; Roy MJ; Robertson RM
    Circulation; 2007 Mar; 115(12):1690-5. PubMed ID: 17506124
    [No Abstract]   [Full Text] [Related]  

  • 54. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs.
    Madjid M; Luepker RV; Greenlund KJ; Taubert KA; Roy MJ; Robertson RM
    J Am Coll Cardiol; 2007 Mar; 49(12):1407-12. PubMed ID: 17394982
    [No Abstract]   [Full Text] [Related]  

  • 55. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
    Anderson JL; Heidenreich PA; Barnett PG; Creager MA; Fonarow GC; Gibbons RJ; Halperin JL; Hlatky MA; Jacobs AK; Mark DB; Masoudi FA; Peterson ED; Shaw LJ
    J Am Coll Cardiol; 2014 Jun; 63(21):2304-22. PubMed ID: 24681044
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant vaccinia viruses as live virus vectors for vaccine antigens: memorandum from a WHO/USPHS/NIBSC meeting.
    Bull World Health Organ; 1985; 63(3):471-7. PubMed ID: 2994898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection.
    Khan AS; Ng SHS; Vandeputte O; Aljanahi A; Deyati A; Cassart JP; Charlebois RL; Taliaferro LP
    mSphere; 2017; 2(5):. PubMed ID: 28932815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases.
    Cooper LT; Mensah GA; Baddour LM; Dunbar SB; Kaplan EL; Wilson WR; Shah PK
    Circulation; 2007 Mar; 115(12):1681-9. PubMed ID: 17506122
    [No Abstract]   [Full Text] [Related]  

  • 59. ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases.
    Cooper LT; Mensah GA; Baddour LM; Dunbar SB; Kaplan EL; Wilson WR; Shah PK
    J Am Coll Cardiol; 2007 Mar; 49(12):1398-406. PubMed ID: 17394981
    [No Abstract]   [Full Text] [Related]  

  • 60. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.
    American Society of Anesthesiologists Task Force on Acute Pain Management
    Anesthesiology; 2012 Feb; 116(2):248-73. PubMed ID: 22227789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.